Lantern Pharma Inc. (LTRN) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$3.95
-2.95%
Mkt Cap $29.86M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | — | — | — | -$0.46 | -$0.36 | +21.74% |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.46 | -$0.39 | +15.22% |
| Q3 2025 Aug 13, 2025 | — | — | — | -$0.53 | -$0.40 | +24.53% |
| Q2 2025 May 15, 2025 | — | — | — | -$0.49 | -$0.42 | +14.29% |
| Q1 2025 Mar 27, 2025 | — | $100.65K | — | -$0.51 | -$0.54 | -5.88% |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.56 | -$0.42 | +25.00% |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.55 | -$0.46 | +16.36% |
| Q2 2024 May 9, 2024 | — | — | — | -$0.43 | -$0.51 | -18.60% |
| Q1 2024 Mar 18, 2024 | — | $261.05K | — | -$0.40 | -$0.39 | +2.50% |
| Q4 2023 Nov 8, 2023 | — | — | — | -$0.45 | -$0.29 | +35.56% |
| Q3 2023 Aug 9, 2023 | — | — | — | -$0.43 | -$0.44 | -2.33% |
| Q2 2023 May 9, 2023 | — | — | — | -$0.48 | -$0.36 | +25.00% |
| Q1 2023 Mar 20, 2023 | — | — | — | -$0.47 | -$0.31 | +34.04% |
| Q4 2022 Nov 7, 2022 | — | — | — | -$0.48 | -$0.21 | +56.25% |
| Q3 2022 Aug 8, 2022 | — | — | — | -$0.52 | -$0.41 | +21.15% |
| Q2 2022 May 3, 2022 | — | — | — | -$0.29 | -$0.38 | -31.03% |
| Q1 2022 Mar 10, 2022 | — | — | — | -$0.40 | -$0.32 | +20.00% |
| Q4 2021 Nov 1, 2021 | — | — | — | -$0.27 | -$0.36 | -33.33% |
| Q3 2021 Jul 29, 2021 | — | — | — | -$0.26 | -$0.21 | +19.23% |
| Q2 2021 May 3, 2021 | — | — | — | -$0.27 | -$0.24 | +11.11% |
| Q1 2021 Mar 10, 2021 | — | — | — | -$0.45 | -$0.47 | -4.44% |
| Q4 2020 Oct 29, 2020 | — | — | — | -$0.33 | -$0.27 | +18.18% |
| Q3 2020 Jul 30, 2020 | — | — | — | -$0.37 | -$0.31 | +16.22% |
| Q2 2020 Jun 12, 2020 | — | — | — | — | -$0.08 | — |
| Q4 2019 Dec 31, 2019 | — | — | — | — | -$0.11 | — |
| Q3 2019 Sep 30, 2019 | — | — | — | — | -$0.11 | — |
| Q2 2019 Jun 30, 2019 | — | — | — | — | -$0.10 | — |
| Q1 2019 Mar 31, 2019 | — | — | — | — | -$0.07 | — |